Circulating microRNA a novel prognostic and diagnostic biomarker of prediabetes, Type 2 Diabetes and its complications among Indians.
Project Description
Type 2 diabetes mellitus (T2DM) has reached epidemic proportions and is associated with various consequences. India is been reported as one of the epi center of this ongoing burden of the T2DM. Currently used therapies aim to delay progression of T2DM. Their efficacy could drastically be improved if implemented at earlier stages. Classical diagnostic markers are generally detected once metabolic imbalance has already set in. Therefore, development
of biomarkers for early diagnosis would help identify individuals at risk for developing
T2DM and its complication. MicroRNA-based prognosis, diagnosis, and disease
management are emerging as a novel idea in the context of T2DM. The expression level of
miRNAs not only offers an assessment of pathological state of disease, but also been proposed to be used as a therapeutics target in the near future. Utility of microRNA based
analysis as potential diagnostic and prognostic markers has never been studied among
Indians. Even when studied in the available literature targeted specific microRNA
particularly among prediabetes and diabetes with spectrum of complications are limited. The
implications of lifestyle modification on the reversibility of glycaemia in context to
microRNA is hardly been evaluated. In this study we propose to study the potential role of
circulating microRNA as a prognostic and early diagnostic markers among Indians with
T2DM. Current study will also follow the prediabetes population for 16 weeks to assess the
role of lifestyle modification on the circulating microRNA levels.
Project Duration
2019 - 2025
Project Lead
Dr Sucharitha S
Authors
Dr Sucharita S. Dr Jyothi P, Dr Ashwini P
Project Status
completed
Project Type
RGUHS